Article ISI
EBIOMEDICINE  (2021)

The altered serum lipidome and its diagnostic potential for Non-Alcoholic Fatty Liver (NAFL)-associated hepatocellular carcinoma

Lewinska, Monika; Santos-Laso, Alvaro; Zhuravleva, Ekaterina; Jimenez-Aguero, Raul; Eizaguirre, Emma; Jesus Pareja, Maria; Suppli, Malte P.; Knop, Filip K.; Oversoe, Stine Karlsen; Villadsen, Gerda Elisabeth; Decaens, Thomas; Carrilho, Flair Jose; de Oliveira, Claudia P. M. S.; Sangro, Bruno

Abstract

Background: Non-alcoholic fatty liver disease (NAFLD) is affecting more people globally. Indeed, NAFLD is a spectrum of metabolic dysfunctions that can progress to hepatocellular carcinoma (NAFLD-HCC). This development can occur in a non-cirrhotic liver and thus, often lack clinical surveillance. The aim of this study was to develop non-invasive surveillance method for NAFLD-HCC.

Más información

Título según WOS: The altered serum lipidome and its diagnostic potential for Non-Alcoholic Fatty Liver (NAFL)-associated hepatocellular carcinoma
Título de la Revista: EBIOMEDICINE
Volumen: 73
Editorial: Elsevier
Fecha de publicación: 2021
DOI:

10.1016/J.EBIOM.2021.103661
Notas: ISI